Tirzepatide
Find your strength. Choose your bundle.
A closer
look.
Research details & references
Last reviewed:
What is Tirzepatide?
Tirzepatide is a synthetic research compound studied in controlled laboratory environments for its involvement in incretin-signalling, metabolic regulation, glucose signalling, and appetite-related pathways. Lazarus Labs supplies pharmaceutical-grade Tirzepatide in Australia in selectable strength options designed for precision, purity, and reproducibility in advanced research applications.
Why researchers choose Lazarus Labs
Produced in a GMP-compliant and ISO-certified facility, every batch of Tirzepatide is independently verified for ≥99% purity using HPLC and LC-MS analysis, with a certificate of analysis available for every batch. Our meticulous synthesis process supports consistent molecular accuracy, solubility, and stability for advanced metabolic and receptor-binding research.
Product highlights
- Purity: ≥99% (independently verified)
- Available sizes: 10MG and 30MG research vial options
- Solubility: Fully soluble in water (H2O)
- Use: Designed for incretin, metabolic, and receptor-binding research
- Manufacturing: GMP + ISO 9001:2008 compliant
- Form: White lyophilised powder for long-term stability
Handling & storage
Store sealed and dry at 2-8 °C. Follow your internal laboratory handling and stability procedures after preparation.
Read the citation-backed research overview →
Cited research
- Coskun T, Sloop KW, Loghin C, et al. Molecular Metabolism. 2018. PMID: 30473097.
- Willard FS, Douros JD, Gabe MB, et al. JCI Insight. 2020. PMID: 32730231.
- Sun B, Willard FS, Feng D, et al. Proceedings of the National Academy of Sciences. 2022. PMID: 35333651.
Primary literature, verified against PubMed. Cited for scientific reference only — no human-use indication is implied.
The finer
details.
Check the product format, available strengths and intended use.
- Size
- 10MG, 30MG
- Product
- Tirzepatide
- Intended use
- Laboratory research only
- Documentation
- See COA tab for strength and batch reports
Read the report.
Know the batch.
Compare the product, strength and batch on your vial with the original laboratory document.
Supplier batch report
- Batch
- LL-TIRZEPATIDE-0125
- Report
- #206259
- Tested
- 2026-07-27
- Reported purity
- 99.634%
Reports identify tested batches. The available reports do not establish which batch will be dispatched with your order.
WA dispatch.
Tracked delivery.
Orders are dispatched from Western Australia with tracking. Check the selected product's availability and any pre-order notice before ordering.
Pre-order items follow their stated dispatch estimate. Orders containing pre-order items ship together once everything is available.
Shipping details →
